Publication: Mortality in psoriatic arthritis patients, changes over time, and the impact of covid-19: Results from a multicenter psoriatic arthritis registry (psart-id)
Date
Authors
Dalkılıç, Ediz
Authors
Erden, Abdulsamet
Ayan, Gizem
Kılıç, Levent
Solmaz, Dilek
Bakırcı, Sibel
Kimyon, Gezmis
Günal, Esen Kasapoğlu
Dogru, Atalay
Bayındır, Özün
Özisler, Cem
Advisor
Language
Publisher:
Springer London Ltd
Journal Title
Journal ISSN
Volume Title
Abstract
BackgroundThis study aimed to assess the mortality of PsA before and during the COVID-19 pandemic.MethodsFrom the prospective, multicenter PsART-ID (Psoriatic Arthritis Registry-International Database), patients from Turkey were analyzed by linking the registry to the Turkish Cause of Death Registry. The outcome of interest was death from any cause, pre-pandemic (since the onset of registry-March 2014-March 2020), and during the pandemic (March 2020-May 2021). The crude mortality rate and standardized mortality ratio (SMR) were determined.ResultsThere were 1216 PsA patients with a follow-up of 7500 patient-years. Overall, 46 deaths (26 males) were observed. In the pre-pandemic period, SMR for PsA vs the general population was 0.95 (0.61-1.49), being higher in males [1.56 (0.92-2.63)] than females [0.62 (0.33-1.17)]. The crude mortality rate in PsA doubled during the pandemic (pre-pandemic crude mortality rate: 5.07 vs 10.76 during the pandemic) with a higher increase in females (2.9 vs 8.72) than males (9.07 vs 14.73).ConclusionThe mortality in PsA was found similar to the general population in the pre-pandemic era. The mortality rates in PsA doubled during the pandemic. Whether PsA patients have more risk of mortality than the general population due to COVID-19 needs further studies.
Description
Source:
Keywords:
Keywords
Mortality, Pandemic, Psoriatic arthritis, Covid-19, Science & technology, Life sciences & biomedicine, Rheumatology